ASYLIA DIAGNOSTICS
Asylia Diagnostics is a diagnostics technology platform intended to provide safer immunotherapy for cancer patients. We collect molecular and real-world evidence data from patients treated with investigational drugs in clinical trials and patients treated by the standard of care. We then use our data platform and AI-powered technology to transform these highly heterogeneous patient populations into well-defined subgroups that share common molecular and immuno-pathophysiology profiles. By doing t... his, we are able to identify highly specific biomarkers and novel drug targets. We then use discovered endotypes, biomarkers, and drug targets to develop patient stratification, enrichment, and indication expansion strategies, early hits/leads for the therapeutic pipeline, and eventually complex theranostic products together with our biopharma and IVD partners.
ASYLIA DIAGNOSTICS
Social Links:
Industry:
Artificial Intelligence (AI) Biotechnology Health Care Life Science Precision Medicine
Founded:
2019-08-22
Address:
Delaware City, Delaware, United States
Country:
United States
Website Url:
http://www.asyliadx.com
Total Employee:
1+
Status:
Active
Contact:
+32 492 40 40 24
Email Addresses:
[email protected]
Total Funding:
1.1 M USD
Technology used in webpage:
Euro Google Google Cloud Wix
Similar Organizations
Akello
Open Source Health Data Platform for Enterprise
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Perceiv AI
AI-driven precision medicine, forecasting disease progression
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapyโbased treatments for cardiovascular disease.
SF17 Therapeutics
SF17 Therapeutics is a precision medicine analytics platform.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Founder
Investors List
imec
imec investment in Seed Round - Asylia Diagnostics
Davidovs Venture Collective
Davidovs Venture Collective investment in Seed Round - Asylia Diagnostics
BlueHealth Innovation Center
BlueHealth Innovation Center investment in Seed Round - Asylia Diagnostics
Official Site Inspections
http://www.asyliadx.com Semrush global rank: 13.31 M Semrush visits lastest month: 78
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Asylia Diagnostics"
Asylia Diagnostics
Asylia Diagnostics focuses on the field of immunotherapies. We collect molecular, chemical and real-world evidence data. Our data come from patients treated with investigational drugs in clinical trials, from patients treated by the standard of โฆSee details»
HOME | Asylia Diagnostics
Asylia Diagnostics is a precision medicine company focusing on the field of immunotherapies. We collect molecular and real-world evidence data from patients treated with investigational drugs in clinical trials and patients treated โฆSee details»
ABOUT - Asylia Diagnostics
Asylia has set up a multi-disciplinary scientific team uniquely positioned to deliver precision medicine tools thanks to a combination of technical, biological, and laboratory skills acquired โฆSee details»
Asylia Diagnostics - Crunchbase Company Profile
Asylia Diagnostics is a diagnostics technology platform intended to provide safer immunotherapy for cancer patients. We collect molecular and real-world โฆSee details»
Asylia Diagnostics - Overview, News & Similar companies
View Asylia Diagnostics (www.asyliadx.com) location in Belgium , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Asylia Diagnostics - PitchBook
Asylia Diagnostics General Information Description. Developer of molecular diagnostics tests designed to provide safer immunotherapy for cancer patients. The company's approach is โฆSee details»
Asylia Diagnostics BV - Drug pipelines, Patents, Clinical trials
Last update 01 Nov 2024. Asylia Diagnostics BVSee details»
Asylia Diagnostics BV - LinkedIn
Asylia Diagnostics BV | 333 followers on LinkedIn. Diagnostics technology platform intended to provide safer immunotherapy for cancer patients | Asylia, a precision medicine platform, โฆSee details»
Asylia Diagnostics - VentureRadar
"Asylia Diagnostics is a data-driven company specializing in the field of immunotherapies. They leverage a proprietary generative AI platform, AsyliaAIโข, to analyze multi-modal datasets โฆSee details»
Asylia Diagnostics | VentureRadar
Website: https://www.asyliadx.com/ Asylia Diagnostics is a data-driven company specializing in the field of immunotherapies. They leverage a proprietary generative AI ...See details»
Asylia Diagnostic - CMOCRO
Asylia Diagnostics are building a technology platform that will permit a quick and efficient high-resolution profiling of tumor microenvironment, different immune cells and their subtypes, and โฆSee details»
Startup story Asylia Diagnostics - Imec.istart
Oct 21, 2020 Immunotherapy is becoming more and more effective in fighting cancer. Asylia Diagnostics develops tests to make the innovative therapy safer. โBelgium is a frontrunner in โฆSee details»
Asylia Diagnostics BV (Asylia Diagnostics BV) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ โฆ
The recent approval of ICB treatments targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death-1 (PD-1/PD-L1) by the US Food and Drug Administration has offered โฆSee details»
Asylia Diagnostics - Products, Competitors, Financials, Employees ...
Asyliadx.com. Overview & Products; Financials; People; Founded Year 2016. Stage Seed VC | Alive. Total Raised $250K. Last Raised $190K | 3 yrs ago. About Asylia Diagnostics. Asylia โฆSee details»
OUR APPROACH | Asylia Diagnostics
At the core of our technology is back-translation - a transformative concept that leverages molecular and clinical RWE data and machine learning/AI and allows us to de-risk upfront โฆSee details»
Working at Asylia Diagnostics - Glassdoor
See what employees say it's like to work at Asylia Diagnostics . Salaries, reviews, and more - all posted by employees working at Asylia Diagnostics .See details»
PIPELINE - Asylia Diagnostics
Each disease area and drug program in our pipeline takes us one step closer to transforming preclinical R&D using computational biology, real-world evidence data, and fast โฆSee details»
NEWS - Asylia Diagnostics
Our CEO Andrey Khmelevskiy had an interview with Sofie Van Poucke for Invest in Flanders.They discussed why what we do in Asylia Diagnostics BV is important for clinicians and cancer โฆSee details»
News - Asylia Diagnostics
JLABS @ BE, Janssen Pharmaceutica NV Beerse Site 1, Turnhoutseweg 30, 2340 Beerse, Belgium. [email protected]. ContactSee details»